+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity

(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity

Journal of Medicinal Chemistry 38(1): 28-33

The indolonaphthyridine 8 is described as a selective 5-HT2C/2B vs 5-HT2A receptor antagonist. The compound was synthesized in seven steps starting from indoline and isonicotinic acid chloride. The key step is a photocyclization of the indolinyl tetrahydropyridinocarbamic acid ethyl ester 4 to the cis-octahydroindolo[1, 7-bc][2,6]naphthyridinecarbamic acid ethyl ester 5. The synthesis was accomplished by reduction with aluminum hydride and racemic resolution. The indolonaphthyridine 8 exerted the binding profile of a selective 5-HT2C receptor ligand (pKD 7.8) and behaved as an antagonist on the 5-HT-induced accumulation of inositol phosphates in pig choroid plexus cells (pKB 7.13). Compound 8 dose-dependently inhibited the ACTH response to MK-212 in rats and the MK-212-induced hypophagic effect with an ID50 value of 0.3 mg/kg sc. Compound 8 acted as a 5-HT2B receptor antagonist at the rat stomach fundus with a pKB value of 7.34.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 042008172

Download citation: RISBibTeXText

PMID: 7837236

Related references

(+)-cis-4,5,7a,8,9,10,11,11a-Octahydro-7H-10-methylindolo[1,7-bc][2,6]- naphthyridine: A 5-Ht2C/2B Receptor Antagonist with Low 5-Ht2A Receptor Affinity. Journal of Medicinal Chemistry 38(1): 28-33, 1995

Is the apparent antipsychotic action of the 5-HT2A receptor antagonist M100907 counteracted by concomitant 5-HT2C receptor antagonist treatment?. Society for Neuroscience Abstracts 24(1-2): 1369, 1998

Effects of the 5-HT2A receptor antagonist, MDL 100,907 and the 5-HT2C receptor antagonist, SB 206553, on lordosis responding of female rats. Society for Neuroscience Abstracts 24(1-2): 1924, 1998

The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds. European Journal of Pharmacology 388(1): 57-67, 2000

5-HT2c receptor antagonists, but not a 5-HT2A or 5-HT2B receptor antagonist, attenuate haloperidol-induced catalepsy in rat. British Journal of Pharmacology 125(PROC Suppl. ): 65P, 1998

Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement. Neuropharmacology 62(7): 2288-2298, 2012

Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat. European Journal of Pharmacology 553(1-3): 163-170, 2006

(1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity. European Journal of Pharmacology 615(1-3): 1-9, 2009

Differential effects of the 5-HT2A receptor antagonist MDL100,907 and the 5-HT2C receptor antagonist SB242,084 on cocaine induced locomotor activity, cocaine self-administration and cocaine induced reinstatement of responding. Society for Neuroscience Abstracts 27(1): 1176, 2001

Functional characteristics of serotonin 5-HT2A and 5-HT2C receptors in the brain and the expression of the 5-HT2A and 5-HT2C receptor genes in aggressive and non-aggressive rats. Neuroscience and Behavioral Physiology 40(4): 357-361, 2010

Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling. Life Sciences 73(2): 193-207, 2003

Anxiety-related behaviours on the unstable elevated exposed plus maze are enhanced by meta-chlorophenylpiperazine, a 5-HT2C/2B receptor agonist, and inhibited by SB 242084, a selective 5-HT2C receptor antagonist. Society for Neuroscience Abstracts 26(1-2): Abstract No -659 7, 2000

R-fluoxetine has affinity for 5-HT2A and 5-HT2C receptor subtypes as well as 5-HT uptake sites and increases extracellular levels of serotonin, dopamine and norepinephrine in rat prefrontal cortex. Society for Neuroscience Abstracts 26(1-2): Abstract No -684 5, 2000

Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor. Journal of Pharmacological Sciences 102(2): 189-195, 2006

Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo. Journal of Pharmacology and Experimental Therapeutics 339(1): 99, 2011